Pros of GLP-1s: High efficacy, rapid weight loss, and strong appetite control
[5] [10] By activating the GLP-1 receptor, retatrutide is thought to stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, and reduce appetite
As of 2023, the Indian government has allocated INR 500 crore to support research in drug delivery technologies, encouraging local pharmaceutical companies to invest in enhancing delivery methods for chronic conditions like diabetes
Kelly Broster, PhD, is Senior Manager of Pharma & Biopharma Market Development and Collaborations at Thermo Fisher Scientific
This dual approach supports shared decision-making about whether compounded semaglutide, branded alternatives, or other peptide therapies best align with your clinical needs and biological predispositions